Led by Inserm and CEA, the program brings together key stakeholders in French research, including:

The PEPR involves more than 59 laboratories associated to 29 universities and Grandes Écoles and at least 3 hospitals.

The support provided to the priority projects by the industrial integrators of the Grand Défi “Biomedicaments” is one of the key factors in the PEPR success. These integrators, which have a dual specialisation in Biotherapies and Bioproduction, enhance the expertise and skills of PEPR projects and help accelerating technological development and transfer to industry.

Bringing together stakeholders from French research and industry in the field of biotherapies and their biomanufacturing will enable them to capitalise on their knowledge and efforts, with the ultimate aim of creating a solid national ecosystem.